The high expression of PD-L1 resulting from this abnormality forms one of the molecular pathogenetic bases for the CHL tumor microenvironment and evidence for using immune checkpoint inhibitors [26]. The gene discussed is CD274; the disease is classic Hodgkin lymphoma.